EUVIMEDEUVIMED entdecken
Crossref

Development and Validation of a New Reversed Phase HPLC Method for the Quantitation of Azithromycin and Rifampicin in a Capsule Formulation

Foram Patel, Rajendra Kotadiya iD, Rashmin Patel iD, Mrunali Patel iD

Journal of Chromatographic Science · 2024

DOI: 10.1093/chromsci/bmae006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chromatographic Science, 2024. Verfasst von Foram Patel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quality Assurance, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology (CHARUSAT), CHARUSAT Campus, Chan…. Hauptthemen laut MEDLINE: Azithromycin, Rifampin, Capsules, Chromatography, Reverse-Phase. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This research aimed to develop a new method for simultaneously estimating the presence of azithromycin (AZT) and rifampicin (RIF) in a capsule formulation using reverse-phase high-performance liquid chromatography. The developed method utilized a Gemini column with a 60:40% v/v acetonitrile and potassium dihydrogen phosphate mobile phase, a flow rate of 1 mL/min, and an injection volume of 20 μL. The detection wavelengths of 210 and 254 nm for AZT and RIF, respectively, were used. Validation ensures specificity with a peak purity index > 0.99999 for AZT and >0.99995 for RIF, affirming unambiguous analyte detection. The system suitability test, within acceptable limits, validates method reliability. Linearity calibration curves (R2 = 0.998) cover a 25–150% target concentration range. Accuracy studies employing the standard addition method yield recovery values between 96.6 and 103.9% for both drugs, confirming method accuracy. Precision studies reveal % relative standard deviation values consistently below 2%, highlighting reproducibility. Robustness testing supports method reliability under varying conditions. Application to a pharmaceutical capsule formulation demonstrates the method’s practicality, accurately quantifying AZT (98.30%) and RIF (99.37%). This study provides a validated analytical approach for simultaneous quantification in commercial pharmaceutical products containing both drugs, enhancing pharmaceutical quality control for critical antibiotics in complex formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzithromycinRifampinCapsulesChromatography, Reverse-PhaseLimit of DetectionChromatography, High Pressure LiquidReproducibility of ResultsLinear Models

Substanzen

AzithromycinRifampinCapsules

Autor:innen und Institutionen

  • Department of Quality Assurance, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology (CHARUSAT), CHARUSAT Campus, Changa, Dist-Anand, Gujarat 388421, India.

ORCID-Profile: Rajendra Kotadiya, Rashmin Patel, Mrunali Patel

Zitieren

APA

Patel, F., Kotadiya, R., Patel, R., & Patel, M. (2024). Development and Validation of a New Reversed Phase HPLC Method for the Quantitation of Azithromycin and Rifampicin in a Capsule Formulation. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmae006

Vancouver

Patel F, Kotadiya R, Patel R, Patel M. Development and Validation of a New Reversed Phase HPLC Method for the Quantitation of Azithromycin and Rifampicin in a Capsule Formulation. Journal of Chromatographic Science. 2024. doi:10.1093/chromsci/bmae006

BibTeX
@article{Patel2024,
  author = {Patel, Foram and Kotadiya, Rajendra and Patel, Rashmin and Patel, Mrunali},
  title = {Development and Validation of a New Reversed Phase HPLC Method for the Quantitation of Azithromycin and Rifampicin in a Capsule Formulation},
  journal = {Journal of Chromatographic Science},
  year = {2024},
  doi = {10.1093/chromsci/bmae006}
}
Kostenlos starten →